Vical to Host Virtual Research & Development Day on May 2, 2017
April 24 2017 - 6:30AM
Vical Incorporated (Nasdaq:VICL) today announced that it will host
a virtual Research & Development Day for analysts, investors
and media on Tuesday, May 2, 2017, beginning at 9:00 a.m. PT. This
event will be available via webcast and conference call.
The event will provide a comprehensive overview
of Vical’s product pipeline with an emphasis on the HSV-2 and
invasive aspergillosis programs, including presentations by members
of the Vical leadership team and two leading experts:
- Anna Wald, MD, MPH, Professor, Department of Medicine,
Epidemiology and Laboratory Medicine at the University of
Washington and Lead Investigator in the ongoing Phase 2 trial of
Vical’s HSV-2 therapeutic vaccine candidate
- Haran Schlamm, MD, infectious disease specialist and former
Senior Medical Director at Pfizer, responsible for clinical
development, medical and regulatory affairs for Pfizer’s antifungal
portfolio
Listeners may access the accompanying slide
presentation through the webcast at www.vical.com. The call and
webcast are open on a listen-only basis to any interested parties.
To listen to the conference call, dial in approximately ten minutes
before the scheduled call to (719) 325-2239 (preferred), or (888)
455-2308 (toll-free), and reference confirmation code 9084195. A
replay of the call will be available for 48 hours beginning about
two hours after the call. To listen to the replay, dial (719)
457-0820 (preferred) or (888) 203-1112 (toll-free) and enter replay
passcode 9084195. The call also will be available live and archived
through the events page at www.vical.com. For further information,
contact Vical’s Investor Relations department by phone at (858)
646-1127 or by e-mail at ir@vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, based on its
patented DNA delivery technologies and other therapeutic
approaches. Additional information on Vical is available at
www.vical.com.
Contact:
Tony Ramos
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Apr 2023 to Apr 2024